Curcumin inhibits expression of inhibitor of DNA binding 1 in PC3 cells and xenografts

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 3, 2014, Pages 1465-1470

  Yu, Xiao Ling ^a   Jing, Tao ^b   Zhao, Hui ^c   Li, Pei Jie ^a   Xu, Wen Hua ^a   Shang, Fang Fang ^c  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b QINGDAO UNIVERSITY   (China)

^c 401 Hospital of PLA   (China)

Author keywords

Curcumin; Id1; PC3 cells; Prostate cancer; Tumor growth; Xenograft

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; INHIBITOR OF DIFFERENTIATION 1; SMALL INTERFERING RNA;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; GENETICS; HUMAN; MALE; MOUSE; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CURCUMIN; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84896825040     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.3.1465     Document Type: Article

References (40)

1. Ao J, Meng J, Zhu L, et al (2012). Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion. Mol Oncol, 6, 507-15.
2. Ahlqvist K, Saamarthy K, Syed Khaja AS, Bjartell A, Massoumi R (2013). Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer. Oncogene, 12, 1601-8.
3. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H (1990). The protein Id: a negative regulator of helix-loophelix DNA binding proteins. Cell, 61, 49-59.
4. Cheng YJ, Tsai JW, Hsieh KC, et al (2011). Id1 promotes lung cancer cell proliferation and tumor growth through Aktrelated pathway. Cancer Lett, 307, 191-9.
5. Cheng TS, Chen WC, Lin YY, et al (2013). Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis. Cancer Prev Res, 6, 495-505.
6. Castañon E, Bosch-Barrera J, López I, et al (2013). Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy. J Transl Med, 11, 11-3.
7. Cimino S, Sortino G, Favilla V, et al (2012). Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxid Med Cell Longev, 2012, 632959.
8. Dong Z, Wei F, Zhou C, et al (2011). Silencing Id-1 inhibits lymphangiogenesis through down-regulation of VEGF-C in oral squamous cell carcinoma. Oral Oncol, 47, 27-32.
9. Datta R, Halder SK, Zhang B (2013). Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells. J Cancer Res Clin Oncol, 4, 563-72.
10. Forootan S, Wong Y, Dodson A, et al (2007). Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer. Hum Pathol, 38, 1321-9.
11. Goel A, Aggarwal BB (2010). Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutrition and Cancer, 62, 919-30.
12. Gupta SC, Patchva S, Aggarwal BB (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J, 1, 195-218.
13. Hai-Tao Yin, De-Geng Zhang, Xiao-Li Wu, Xin-En Huang, Gang Chen (2013). In Vivo Evaluation of Curcumin-loaded Nanoparticles in a A549 Xenograft Mice Model. Asian Pacifc Journal of Cancer Prevention, 14, 409-12
14. Hsiao YC, Yang DL, Hung HL, Lung FD (2013). Structure activity relationships of peptidic analogs of MyoD for the development of Id1 inhibitors as antiproliferative agents. J Pept Sci, 11, 676-83.
15. Hilchie AL, Furlong SJ, Sutton K, et al (2010). Curcumininduced apoptosis in PC3 prostate carcinoma cells is caspaseindependent and involves cellular ceramide accumulation and damage to mitochondria. Nutr Cancer 62:379-89.
16. Horie S (2012). Chemoprevention of prostate cancer: soy isoflavones and curcumin. Korean J Urol, 53, 665-72.
17. J. Yang, X. Li, R.S. Al-Lamki, et al (2010). Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo. Circ Res, 107, 252-62.
18. Kang D, Park W, Lee S, Kim JH, Song JJ (2013). Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment. Cell Signal, 25, 1288-300.
19. Killian PH, Kronski E, Michalik KM, et al (2012). Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and-2. Carcinogenesis, 33, 2507-19.
20. Ling M, Lau T, Zhou C, et al (2005). Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis, 26, 1668-76.
21. Ling MT, Kwok WK, Fung MK, Xianghong W, Wong YC (2006). Proteasome mediated degradation of Id-1 is associated with TNFalpha-induced apoptosis in prostate cancer cells. Carcinogenesis, 27, 205-15.
22. Mellick AS, Plummer PN, Nolan DJ, et al (2010). Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth. Cancer Res, 70, 7273-82.
23. Ni X, Zhang A, Zhao Z, Shen Y, Wang S (2012). Demethoxycurcumin inhibits cell proliferation, migration and invasion in prostate cancer cells. Oncol Rep, 8, 85-90.
24. Patel D, Chaudhary J (2012). Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis. Biochem Biophys Res Commun, 1, 146-51.
25. Redrado M, Bodegas E, Villaro AC, et al (2013). Spatialtemporal protein expression of Inhibitor of Differentiation-1 (Id1) during fetal embryogenesis and in different mouse and human cancer types. Histol Histopathol, 8, 1029-40.
26. Rothschild SI, Kappeler A, Ratschiller D, et al (2011). The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer. Lung Cancer, 71, 306-11.
27. Strong N, Millena AC, Walker L, Chaudhary J, Khan SA (2013). Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells. Prostate, 73, 624-33.
28. Sun W, Guo MM, Han P, et al (2012). Id-1 and the p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis. Carcinogenesis, 33, 810-7.
29. Sharma P, Patel D, Chaudhary J (2012). Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B. Cancer Med, 1, 187-97.
30. Soroceanu L, Murase R, Limbad C, et al (2013). Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target. Cancer Res, 73, 1559-69.
31. Teiten MH, Gaigneaux A, Chateauvieux S, et al (2012). Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines. OMICS, 16, 289-300.
32. Wei X, Zhou D, Wang H, et al (2013). Effects of pyridine analogs of curcumin on growth, apoptosis and NF-κB activity in prostate cancer PC-3 cells. Anticancer Res, 33, 1343-50.
33. Wright LE, Frye JB, Lukefahr AL, et al (2013). Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis. J Nat Prod, 3, 316-21.
34. Xiaoling Yu, Xiaohui Xu, Baojian Han, Rongxiang Zhou (2009). Inhibitor of DNA Binding-1 Overexpression in Prostate Cancer: Relevance to Tumor Differentiation. Pathol Oncol Res, 15, 91-6.
35. Y. Kang, C.R. Chen, J. Massague (2003). A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell, 11, 915-26.
36. Yin H, Zhang H, Liu B (2013). Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer. Acta Biochim Biophys Sin, 8, 634-40
37. Yuen HF, Chiu YT, Chan KK, et al (2010). Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1. Br J Cancer, 102, 332-41.
38. Yu XL, Jing T, Shang FF, Zhao H, Qi RF (2011). Down regulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro. Eur J Cancer Prev, 20, 9-17.
39. Y.Y. Liang, F.C. Brunicardi, X. Lin (2009). Smad3 mediates immediate early induction of Id1 by TGF-beta. Cell Res, 19, 140-8.
40. Zhang X, Chen LX, Ouyang L, Cheng Y, Liu B (2012). Plant natural compounds: targeting pathways of autophagy as anticancer therapeutic agents. Cell Prolif, 45, 466-76.